Global NK Cell Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Global NK Cell Therapy Market Size was estimated at USD 409.80 million in 2023 and is projected to reach USD 1008.81 million by 2029, exhibiting a CAGR of 16.20% during the forecast period.
This report provides a deep insight into the global NK Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NK Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NK Cell Therapy market in any manner.
Global NK Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Market Segmentation (by Type)
NK Cell Therapies
NK Cell Directed Antibodies
Market Segmentation (by Application)
Cancer
Gastrointestinal Diseases
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NK Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Global NK Cell Therapy Market Size was estimated at USD 409.80 million in 2023 and is projected to reach USD 1008.81 million by 2029, exhibiting a CAGR of 16.20% during the forecast period.
This report provides a deep insight into the global NK Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NK Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NK Cell Therapy market in any manner.
Global NK Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Market Segmentation (by Type)
NK Cell Therapies
NK Cell Directed Antibodies
Market Segmentation (by Application)
Cancer
Gastrointestinal Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the NK Cell Therapy Market
- Overview of the regional outlook of the NK Cell Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NK Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of NK Cell Therapy
1.2 Key Market Segments
1.2.1 NK Cell Therapy Segment by Type
1.2.2 NK Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NK CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NK Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NK Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NK CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global NK Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global NK Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NK Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NK Cell Therapy Sales Sites, Area Served, Product Type
3.6 NK Cell Therapy Market Competitive Situation and Trends
3.6.1 NK Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest NK Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NK CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 NK Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NK CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NK CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NK Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global NK Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global NK Cell Therapy Price by Type (2019-2024)
7 NK CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NK Cell Therapy Market Sales by Application (2019-2024)
7.3 Global NK Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
8 NK CELL THERAPY MARKET SEGMENTATION BY REGION
8.1 Global NK Cell Therapy Sales by Region
8.1.1 Global NK Cell Therapy Sales by Region
8.1.2 Global NK Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America NK Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NK Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NK Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NK Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NK Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Nektar Therapeutics
9.1.1 Nektar Therapeutics NK Cell Therapy Basic Information
9.1.2 Nektar Therapeutics NK Cell Therapy Product Overview
9.1.3 Nektar Therapeutics NK Cell Therapy Product Market Performance
9.1.4 Nektar Therapeutics Business Overview
9.1.5 Nektar Therapeutics NK Cell Therapy SWOT Analysis
9.1.6 Nektar Therapeutics Recent Developments
9.2 Innate Pharma SA
9.2.1 Innate Pharma SA NK Cell Therapy Basic Information
9.2.2 Innate Pharma SA NK Cell Therapy Product Overview
9.2.3 Innate Pharma SA NK Cell Therapy Product Market Performance
9.2.4 Innate Pharma SA Business Overview
9.2.5 Innate Pharma SA NK Cell Therapy SWOT Analysis
9.2.6 Innate Pharma SA Recent Developments
9.3 Affimed
9.3.1 Affimed NK Cell Therapy Basic Information
9.3.2 Affimed NK Cell Therapy Product Overview
9.3.3 Affimed NK Cell Therapy Product Market Performance
9.3.4 Affimed NK Cell Therapy SWOT Analysis
9.3.5 Affimed Business Overview
9.3.6 Affimed Recent Developments
9.4 Chipscreen Biosciences
9.4.1 Chipscreen Biosciences NK Cell Therapy Basic Information
9.4.2 Chipscreen Biosciences NK Cell Therapy Product Overview
9.4.3 Chipscreen Biosciences NK Cell Therapy Product Market Performance
9.4.4 Chipscreen Biosciences Business Overview
9.4.5 Chipscreen Biosciences Recent Developments
9.5 Fate Therapeutics
9.5.1 Fate Therapeutics NK Cell Therapy Basic Information
9.5.2 Fate Therapeutics NK Cell Therapy Product Overview
9.5.3 Fate Therapeutics NK Cell Therapy Product Market Performance
9.5.4 Fate Therapeutics Business Overview
9.5.5 Fate Therapeutics Recent Developments
9.6 Glycostem Therapeutics
9.6.1 Glycostem Therapeutics NK Cell Therapy Basic Information
9.6.2 Glycostem Therapeutics NK Cell Therapy Product Overview
9.6.3 Glycostem Therapeutics NK Cell Therapy Product Market Performance
9.6.4 Glycostem Therapeutics Business Overview
9.6.5 Glycostem Therapeutics Recent Developments
9.7 Dragonfly Therapeutics
9.7.1 Dragonfly Therapeutics NK Cell Therapy Basic Information
9.7.2 Dragonfly Therapeutics NK Cell Therapy Product Overview
9.7.3 Dragonfly Therapeutics NK Cell Therapy Product Market Performance
9.7.4 Dragonfly Therapeutics Business Overview
9.7.5 Dragonfly Therapeutics Recent Developments
9.8 Kiadis Pharma
9.8.1 Kiadis Pharma NK Cell Therapy Basic Information
9.8.2 Kiadis Pharma NK Cell Therapy Product Overview
9.8.3 Kiadis Pharma NK Cell Therapy Product Market Performance
9.8.4 Kiadis Pharma Business Overview
9.8.5 Kiadis Pharma Recent Developments
9.9 NantWorks
9.9.1 NantWorks NK Cell Therapy Basic Information
9.9.2 NantWorks NK Cell Therapy Product Overview
9.9.3 NantWorks NK Cell Therapy Product Market Performance
9.9.4 NantWorks Business Overview
9.9.5 NantWorks Recent Developments
9.10 Nkarta Therapeutics
9.10.1 Nkarta Therapeutics NK Cell Therapy Basic Information
9.10.2 Nkarta Therapeutics NK Cell Therapy Product Overview
9.10.3 Nkarta Therapeutics NK Cell Therapy Product Market Performance
9.10.4 Nkarta Therapeutics Business Overview
9.10.5 Nkarta Therapeutics Recent Developments
9.11 Fortress Biotech
9.11.1 Fortress Biotech NK Cell Therapy Basic Information
9.11.2 Fortress Biotech NK Cell Therapy Product Overview
9.11.3 Fortress Biotech NK Cell Therapy Product Market Performance
9.11.4 Fortress Biotech Business Overview
9.11.5 Fortress Biotech Recent Developments
10 NK CELL THERAPY MARKET FORECAST BY REGION
10.1 Global NK Cell Therapy Market Size Forecast
10.2 Global NK Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NK Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific NK Cell Therapy Market Size Forecast by Region
10.2.4 South America NK Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NK Cell Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global NK Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NK Cell Therapy by Type (2025-2030)
11.1.2 Global NK Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NK Cell Therapy by Type (2025-2030)
11.2 Global NK Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global NK Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global NK Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of NK Cell Therapy
1.2 Key Market Segments
1.2.1 NK Cell Therapy Segment by Type
1.2.2 NK Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NK CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NK Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NK Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NK CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global NK Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global NK Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NK Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NK Cell Therapy Sales Sites, Area Served, Product Type
3.6 NK Cell Therapy Market Competitive Situation and Trends
3.6.1 NK Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest NK Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NK CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 NK Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NK CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NK CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NK Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global NK Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global NK Cell Therapy Price by Type (2019-2024)
7 NK CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NK Cell Therapy Market Sales by Application (2019-2024)
7.3 Global NK Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
8 NK CELL THERAPY MARKET SEGMENTATION BY REGION
8.1 Global NK Cell Therapy Sales by Region
8.1.1 Global NK Cell Therapy Sales by Region
8.1.2 Global NK Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America NK Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NK Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NK Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NK Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NK Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Nektar Therapeutics
9.1.1 Nektar Therapeutics NK Cell Therapy Basic Information
9.1.2 Nektar Therapeutics NK Cell Therapy Product Overview
9.1.3 Nektar Therapeutics NK Cell Therapy Product Market Performance
9.1.4 Nektar Therapeutics Business Overview
9.1.5 Nektar Therapeutics NK Cell Therapy SWOT Analysis
9.1.6 Nektar Therapeutics Recent Developments
9.2 Innate Pharma SA
9.2.1 Innate Pharma SA NK Cell Therapy Basic Information
9.2.2 Innate Pharma SA NK Cell Therapy Product Overview
9.2.3 Innate Pharma SA NK Cell Therapy Product Market Performance
9.2.4 Innate Pharma SA Business Overview
9.2.5 Innate Pharma SA NK Cell Therapy SWOT Analysis
9.2.6 Innate Pharma SA Recent Developments
9.3 Affimed
9.3.1 Affimed NK Cell Therapy Basic Information
9.3.2 Affimed NK Cell Therapy Product Overview
9.3.3 Affimed NK Cell Therapy Product Market Performance
9.3.4 Affimed NK Cell Therapy SWOT Analysis
9.3.5 Affimed Business Overview
9.3.6 Affimed Recent Developments
9.4 Chipscreen Biosciences
9.4.1 Chipscreen Biosciences NK Cell Therapy Basic Information
9.4.2 Chipscreen Biosciences NK Cell Therapy Product Overview
9.4.3 Chipscreen Biosciences NK Cell Therapy Product Market Performance
9.4.4 Chipscreen Biosciences Business Overview
9.4.5 Chipscreen Biosciences Recent Developments
9.5 Fate Therapeutics
9.5.1 Fate Therapeutics NK Cell Therapy Basic Information
9.5.2 Fate Therapeutics NK Cell Therapy Product Overview
9.5.3 Fate Therapeutics NK Cell Therapy Product Market Performance
9.5.4 Fate Therapeutics Business Overview
9.5.5 Fate Therapeutics Recent Developments
9.6 Glycostem Therapeutics
9.6.1 Glycostem Therapeutics NK Cell Therapy Basic Information
9.6.2 Glycostem Therapeutics NK Cell Therapy Product Overview
9.6.3 Glycostem Therapeutics NK Cell Therapy Product Market Performance
9.6.4 Glycostem Therapeutics Business Overview
9.6.5 Glycostem Therapeutics Recent Developments
9.7 Dragonfly Therapeutics
9.7.1 Dragonfly Therapeutics NK Cell Therapy Basic Information
9.7.2 Dragonfly Therapeutics NK Cell Therapy Product Overview
9.7.3 Dragonfly Therapeutics NK Cell Therapy Product Market Performance
9.7.4 Dragonfly Therapeutics Business Overview
9.7.5 Dragonfly Therapeutics Recent Developments
9.8 Kiadis Pharma
9.8.1 Kiadis Pharma NK Cell Therapy Basic Information
9.8.2 Kiadis Pharma NK Cell Therapy Product Overview
9.8.3 Kiadis Pharma NK Cell Therapy Product Market Performance
9.8.4 Kiadis Pharma Business Overview
9.8.5 Kiadis Pharma Recent Developments
9.9 NantWorks
9.9.1 NantWorks NK Cell Therapy Basic Information
9.9.2 NantWorks NK Cell Therapy Product Overview
9.9.3 NantWorks NK Cell Therapy Product Market Performance
9.9.4 NantWorks Business Overview
9.9.5 NantWorks Recent Developments
9.10 Nkarta Therapeutics
9.10.1 Nkarta Therapeutics NK Cell Therapy Basic Information
9.10.2 Nkarta Therapeutics NK Cell Therapy Product Overview
9.10.3 Nkarta Therapeutics NK Cell Therapy Product Market Performance
9.10.4 Nkarta Therapeutics Business Overview
9.10.5 Nkarta Therapeutics Recent Developments
9.11 Fortress Biotech
9.11.1 Fortress Biotech NK Cell Therapy Basic Information
9.11.2 Fortress Biotech NK Cell Therapy Product Overview
9.11.3 Fortress Biotech NK Cell Therapy Product Market Performance
9.11.4 Fortress Biotech Business Overview
9.11.5 Fortress Biotech Recent Developments
10 NK CELL THERAPY MARKET FORECAST BY REGION
10.1 Global NK Cell Therapy Market Size Forecast
10.2 Global NK Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NK Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific NK Cell Therapy Market Size Forecast by Region
10.2.4 South America NK Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NK Cell Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global NK Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NK Cell Therapy by Type (2025-2030)
11.1.2 Global NK Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NK Cell Therapy by Type (2025-2030)
11.2 Global NK Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global NK Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global NK Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NK Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global NK Cell Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NK Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NK Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NK Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2022)
Table 10. Global Market NK Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NK Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers NK Cell Therapy Product Type
Table 13. Global NK Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NK Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NK Cell Therapy Market Challenges
Table 22. Global NK Cell Therapy Sales by Type (K Units)
Table 23. Global NK Cell Therapy Market Size by Type (M USD)
Table 24. Global NK Cell Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global NK Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global NK Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global NK Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global NK Cell Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global NK Cell Therapy Sales (K Units) by Application
Table 30. Global NK Cell Therapy Market Size by Application
Table 31. Global NK Cell Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global NK Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global NK Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global NK Cell Therapy Market Share by Application (2019-2024)
Table 35. Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global NK Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global NK Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America NK Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe NK Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NK Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America NK Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NK Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Nektar Therapeutics NK Cell Therapy Basic Information
Table 44. Nektar Therapeutics NK Cell Therapy Product Overview
Table 45. Nektar Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Nektar Therapeutics Business Overview
Table 47. Nektar Therapeutics NK Cell Therapy SWOT Analysis
Table 48. Nektar Therapeutics Recent Developments
Table 49. Innate Pharma SA NK Cell Therapy Basic Information
Table 50. Innate Pharma SA NK Cell Therapy Product Overview
Table 51. Innate Pharma SA NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Innate Pharma SA Business Overview
Table 53. Innate Pharma SA NK Cell Therapy SWOT Analysis
Table 54. Innate Pharma SA Recent Developments
Table 55. Affimed NK Cell Therapy Basic Information
Table 56. Affimed NK Cell Therapy Product Overview
Table 57. Affimed NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Affimed NK Cell Therapy SWOT Analysis
Table 59. Affimed Business Overview
Table 60. Affimed Recent Developments
Table 61. Chipscreen Biosciences NK Cell Therapy Basic Information
Table 62. Chipscreen Biosciences NK Cell Therapy Product Overview
Table 63. Chipscreen Biosciences NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chipscreen Biosciences Business Overview
Table 65. Chipscreen Biosciences Recent Developments
Table 66. Fate Therapeutics NK Cell Therapy Basic Information
Table 67. Fate Therapeutics NK Cell Therapy Product Overview
Table 68. Fate Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fate Therapeutics Business Overview
Table 70. Fate Therapeutics Recent Developments
Table 71. Glycostem Therapeutics NK Cell Therapy Basic Information
Table 72. Glycostem Therapeutics NK Cell Therapy Product Overview
Table 73. Glycostem Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Glycostem Therapeutics Business Overview
Table 75. Glycostem Therapeutics Recent Developments
Table 76. Dragonfly Therapeutics NK Cell Therapy Basic Information
Table 77. Dragonfly Therapeutics NK Cell Therapy Product Overview
Table 78. Dragonfly Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Dragonfly Therapeutics Business Overview
Table 80. Dragonfly Therapeutics Recent Developments
Table 81. Kiadis Pharma NK Cell Therapy Basic Information
Table 82. Kiadis Pharma NK Cell Therapy Product Overview
Table 83. Kiadis Pharma NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Kiadis Pharma Business Overview
Table 85. Kiadis Pharma Recent Developments
Table 86. NantWorks NK Cell Therapy Basic Information
Table 87. NantWorks NK Cell Therapy Product Overview
Table 88. NantWorks NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. NantWorks Business Overview
Table 90. NantWorks Recent Developments
Table 91. Nkarta Therapeutics NK Cell Therapy Basic Information
Table 92. Nkarta Therapeutics NK Cell Therapy Product Overview
Table 93. Nkarta Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Nkarta Therapeutics Business Overview
Table 95. Nkarta Therapeutics Recent Developments
Table 96. Fortress Biotech NK Cell Therapy Basic Information
Table 97. Fortress Biotech NK Cell Therapy Product Overview
Table 98. Fortress Biotech NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Fortress Biotech Business Overview
Table 100. Fortress Biotech Recent Developments
Table 101. Global NK Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global NK Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America NK Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe NK Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific NK Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific NK Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America NK Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa NK Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global NK Cell Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global NK Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global NK Cell Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global NK Cell Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global NK Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NK Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global NK Cell Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NK Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NK Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NK Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2022)
Table 10. Global Market NK Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NK Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers NK Cell Therapy Product Type
Table 13. Global NK Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NK Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NK Cell Therapy Market Challenges
Table 22. Global NK Cell Therapy Sales by Type (K Units)
Table 23. Global NK Cell Therapy Market Size by Type (M USD)
Table 24. Global NK Cell Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global NK Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global NK Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global NK Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global NK Cell Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global NK Cell Therapy Sales (K Units) by Application
Table 30. Global NK Cell Therapy Market Size by Application
Table 31. Global NK Cell Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global NK Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global NK Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global NK Cell Therapy Market Share by Application (2019-2024)
Table 35. Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global NK Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global NK Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America NK Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe NK Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NK Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America NK Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NK Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Nektar Therapeutics NK Cell Therapy Basic Information
Table 44. Nektar Therapeutics NK Cell Therapy Product Overview
Table 45. Nektar Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Nektar Therapeutics Business Overview
Table 47. Nektar Therapeutics NK Cell Therapy SWOT Analysis
Table 48. Nektar Therapeutics Recent Developments
Table 49. Innate Pharma SA NK Cell Therapy Basic Information
Table 50. Innate Pharma SA NK Cell Therapy Product Overview
Table 51. Innate Pharma SA NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Innate Pharma SA Business Overview
Table 53. Innate Pharma SA NK Cell Therapy SWOT Analysis
Table 54. Innate Pharma SA Recent Developments
Table 55. Affimed NK Cell Therapy Basic Information
Table 56. Affimed NK Cell Therapy Product Overview
Table 57. Affimed NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Affimed NK Cell Therapy SWOT Analysis
Table 59. Affimed Business Overview
Table 60. Affimed Recent Developments
Table 61. Chipscreen Biosciences NK Cell Therapy Basic Information
Table 62. Chipscreen Biosciences NK Cell Therapy Product Overview
Table 63. Chipscreen Biosciences NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chipscreen Biosciences Business Overview
Table 65. Chipscreen Biosciences Recent Developments
Table 66. Fate Therapeutics NK Cell Therapy Basic Information
Table 67. Fate Therapeutics NK Cell Therapy Product Overview
Table 68. Fate Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fate Therapeutics Business Overview
Table 70. Fate Therapeutics Recent Developments
Table 71. Glycostem Therapeutics NK Cell Therapy Basic Information
Table 72. Glycostem Therapeutics NK Cell Therapy Product Overview
Table 73. Glycostem Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Glycostem Therapeutics Business Overview
Table 75. Glycostem Therapeutics Recent Developments
Table 76. Dragonfly Therapeutics NK Cell Therapy Basic Information
Table 77. Dragonfly Therapeutics NK Cell Therapy Product Overview
Table 78. Dragonfly Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Dragonfly Therapeutics Business Overview
Table 80. Dragonfly Therapeutics Recent Developments
Table 81. Kiadis Pharma NK Cell Therapy Basic Information
Table 82. Kiadis Pharma NK Cell Therapy Product Overview
Table 83. Kiadis Pharma NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Kiadis Pharma Business Overview
Table 85. Kiadis Pharma Recent Developments
Table 86. NantWorks NK Cell Therapy Basic Information
Table 87. NantWorks NK Cell Therapy Product Overview
Table 88. NantWorks NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. NantWorks Business Overview
Table 90. NantWorks Recent Developments
Table 91. Nkarta Therapeutics NK Cell Therapy Basic Information
Table 92. Nkarta Therapeutics NK Cell Therapy Product Overview
Table 93. Nkarta Therapeutics NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Nkarta Therapeutics Business Overview
Table 95. Nkarta Therapeutics Recent Developments
Table 96. Fortress Biotech NK Cell Therapy Basic Information
Table 97. Fortress Biotech NK Cell Therapy Product Overview
Table 98. Fortress Biotech NK Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Fortress Biotech Business Overview
Table 100. Fortress Biotech Recent Developments
Table 101. Global NK Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global NK Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America NK Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe NK Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific NK Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific NK Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America NK Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa NK Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa NK Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global NK Cell Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global NK Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global NK Cell Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global NK Cell Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global NK Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of NK Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NK Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global NK Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global NK Cell Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NK Cell Therapy Market Size by Country (M USD)
Figure 11. NK Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global NK Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NK Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NK Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NK Cell Therapy Market Share by Type
Figure 18. Sales Market Share of NK Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of NK Cell Therapy by Type in 2023
Figure 20. Market Size Share of NK Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of NK Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NK Cell Therapy Market Share by Application
Figure 24. Global NK Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global NK Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global NK Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global NK Cell Therapy Market Share by Application in 2023
Figure 28. Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global NK Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NK Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NK Cell Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NK Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NK Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NK Cell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NK Cell Therapy Sales Market Share by Region in 2023
Figure 44. China NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NK Cell Therapy Sales and Growth Rate (K Units)
Figure 50. South America NK Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NK Cell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NK Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NK Cell Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NK Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NK Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NK Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global NK Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global NK Cell Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of NK Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NK Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global NK Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global NK Cell Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NK Cell Therapy Market Size by Country (M USD)
Figure 11. NK Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global NK Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NK Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NK Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NK Cell Therapy Market Share by Type
Figure 18. Sales Market Share of NK Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of NK Cell Therapy by Type in 2023
Figure 20. Market Size Share of NK Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of NK Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NK Cell Therapy Market Share by Application
Figure 24. Global NK Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global NK Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global NK Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global NK Cell Therapy Market Share by Application in 2023
Figure 28. Global NK Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global NK Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NK Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NK Cell Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NK Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NK Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NK Cell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NK Cell Therapy Sales Market Share by Region in 2023
Figure 44. China NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NK Cell Therapy Sales and Growth Rate (K Units)
Figure 50. South America NK Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NK Cell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NK Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NK Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NK Cell Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NK Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NK Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NK Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global NK Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global NK Cell Therapy Market Share Forecast by Application (2025-2030)
